BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11488569)

  • 1. Calculation of beta-ray dose distributions from ophthalmic applicators and comparison with measurements in a model eye.
    Cross WG; Hokkanen J; Järvinen H; Mourtada F; Sipilä P; Soares CG; Vynckier S
    Med Phys; 2001 Jul; 28(7):1385-96. PubMed ID: 11488569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry of beta-ray ophthalmic applicators: comparison of different measurement methods.
    Soares CG; Vynckier S; Järvinen H; Cross WG; Sipilä P; Flühs D; Schaeken B; Mourtada FA; Bass GA; Williams TT
    Med Phys; 2001 Jul; 28(7):1373-84. PubMed ID: 11488568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
    Mostafa L; Rachid K; Ahmed SM
    Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of dose distributions for 12 106Ru/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code.
    Hermida-López M
    Med Phys; 2013 Oct; 40(10):101705. PubMed ID: 24089895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapolation chamber measurements of 90Sr + 90Y beta-particle ophthalmic applicator dose rates.
    Deasy JO; Soares CG
    Med Phys; 1994 Jan; 21(1):91-9. PubMed ID: 8164595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patch source model for treatment planning of ruthenium ophthalmic applicators.
    Astrahan MA
    Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc, and MCNP.
    Wang R; Li XA
    Med Phys; 2001 Feb; 28(2):134-41. PubMed ID: 11243335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy.
    Wang R; Li XA
    Med Phys; 2000 Nov; 27(11):2528-35. PubMed ID: 11128305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
    Sánchez-Reyes A; Tello JI; Guix B; Salvat F
    Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a high-dose-rate 90Sr-90Y source for intravascular brachytherapy by using the Monte Carlo code PENELOPE.
    Asenjo J; Fernández-Varea JM; Sánchez-Reyes A
    Phys Med Biol; 2002 Mar; 47(5):697-711. PubMed ID: 11931465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEEP, SHALLOW AND EYE LENS DOSES FROM 106Ru/106Rh-A COMPARSION.
    Kumar M; Bakshi AK; Rakesh RB; Ratna P; Kulkarni MS; Datta D
    Radiat Prot Dosimetry; 2017 Nov; 176(3):211-216. PubMed ID: 28115659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration of the 90Sr+90Y ophthalmic and dermatological applicators with an extrapolation ionization minichamber.
    Antonio PL; Oliveira ML; Caldas LV
    Appl Radiat Isot; 2014 Feb; 85():11-3. PubMed ID: 24362457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.
    Flühs D; Anastassiou G; Wening J; Sauerwein W; Bornfeld N
    Med Phys; 2004 Jun; 31(6):1481-8. PubMed ID: 15259651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study.
    Mourtada F; Koch N; Newhauser W
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):454-60. PubMed ID: 16604677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of absolute dose rates for intravascular brachytherapy beta sources.
    Piessens M; Reynaert N
    Phys Med Biol; 2000 Aug; 45(8):2219-31. PubMed ID: 10958190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The water-equivalence of phantom materials for 90Sr-90Y beta particles.
    Buckley LA; Thomadsen BR; DeWerd LA
    Med Phys; 2001 Jun; 28(6):1010-5. PubMed ID: 11439470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy.
    Wang R; Li XA; Lobdell J
    Med Phys; 2003 Jan; 30(1):27-33. PubMed ID: 12557975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy.
    Miften MM; Das SK; Shafman TD; Marks LB
    Med Phys; 2002 Dec; 29(12):2891-6. PubMed ID: 12512724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose distributions for 90Y intravascular brachytherapy sources used with balloon catheters.
    Piessens M; Reynaert N; Potempa J; Thierens H; Wijns W; Verbeke L
    Med Phys; 2002 Jul; 29(7):1562-71. PubMed ID: 12148739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy deposition by a 106Ru/106Rh eye applicator simulated using LEPTS, a low-energy particle track simulation.
    Fuss MC; Muñoz A; Oller JC; Blanco F; Williart A; Limão-Vieira P; Borge MJ; Tengblad O; Huerga C; Téllez M; García G
    Appl Radiat Isot; 2011 Sep; 69(9):1198-204. PubMed ID: 21543231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.